IRD financials
Opus Genetics (IRD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- IRD revenue was $14.20M in fiscal 2025, net income -$49.59M.
IRD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $14.20M | – | -$38.60M | -$49.59M | -0.80 |
| 2024 | $10.99M | – | -$62.07M | -$57.53M | -2.15 |
| 2023 | $19.05M | – | -$10.56M | -$9.99M | -0.46 |
| 2022 | $39.85M | – | $18.23M | $17.89M | 0.87 |
| 2021 | $589.00K | – | -$22.70M | -$56.69M | -3.82 |
| 2020 | $0.00 | – | -$19.97M | -$24.62M | -5.28 |